OFIX
Orthofix Medical Inc

230
Mkt Cap
$572.61M
Volume
144,780.00
52W High
$20.48
52W Low
$10.24
PE Ratio
-4.76
OFIX Fundamentals
Price
$14.41
Prev Close
$14.46
Open
$14.60
50D MA
$14.95
Beta
1.15
Avg. Volume
239,985.13
EPS (Annual)
-$3.30
P/B
1.29
Rev/Employee
$494,734.53
Loading...
Loading...
News
all
press releases
Orthofix Medical Inc. (NASDAQ:OFIX) Given Average Recommendation of "Moderate Buy" by Analysts
Orthofix Medical Inc. (NASDAQ:OFIX - Get Free Report) has received an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the company, MarketBeat Ratings...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Y Intercept Hong Kong Ltd Takes Position in Orthofix Medical Inc. $OFIX
Y Intercept Hong Kong Ltd acquired a new position in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·12d ago
News Placeholder
Bastion Asset Management Inc. Invests $349,000 in Orthofix Medical Inc. $OFIX
Bastion Asset Management Inc. acquired a new stake in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·13d ago
News Placeholder
Barrington Research Issues Positive Forecast for Orthofix Medical (NASDAQ:OFIX) Stock Price
Barrington Research increased their price objective on shares of Orthofix Medical from $17.00 to $18.00 and gave the company an "outperform" rating in a research report on Wednesday...
MarketBeat·14d ago
News Placeholder
Orthofix (OFIX) Beats Q3 Earnings and Revenue Estimates
Orthofix (OFIX) delivered earnings and revenue surprises of +66.67% and +2.65%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·16d ago
News Placeholder
Orthofix Reports Third Quarter 2025 Financial Results
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net...
Business Wire·16d ago
News Placeholder
Orthofix to Participate in Upcoming Investor Conferences
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial...
Business Wire·1mo ago
News Placeholder
Orthofix to Report Third Quarter 2025 Financial Results
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before...
Business Wire·1mo ago
News Placeholder
FMS vs. OFIX: Which Stock Is the Better Value Option?
FMS vs. OFIX: Which Stock Is the Better Value Option?
Zacks·1mo ago
News Placeholder
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
Zacks·2mo ago

Latest OFIX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.